Jessica Hopfield - Net Worth and Insider Trading
Jessica Hopfield Net Worth
The estimated net worth of Jessica Hopfield is at least $8 Million dollars as of 2024-11-06. Jessica Hopfield is the Director of Insulet Corp and owns about 26,917 shares of Insulet Corp (PODD) stock worth over $6 Million. Jessica Hopfield is the Director of Maravai LifeSciences Holdings Inc and owns about 61,852 shares of Maravai LifeSciences Holdings Inc (MRVI) stock worth over $485,538. Jessica Hopfield is also the Director of Radius Health Inc and owns about 12,800 shares of Radius Health Inc (RDUS) stock worth over $415,616. Besides these, Jessica Hopfield also holds Editas Medicine Inc (EDIT) , PhenomeX Inc (CELL) . Details can be seen in Jessica Hopfield's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jessica Hopfield has not made any transactions after 2024-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jessica Hopfield
Jessica Hopfield Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jessica Hopfield owns 5 companies in total, including Editas Medicine Inc (EDIT) , Insulet Corp (PODD) , and Radius Health Inc (RDUS) among others .
Click here to see the complete history of Jessica Hopfield’s form 4 insider trades.
Insider Ownership Summary of Jessica Hopfield
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EDIT | Editas Medicine Inc | 2024-05-13 | director |
| PODD | Insulet Corp | 2024-09-11 | director |
| RDUS | Radius Health Inc | 2019-03-05 | director |
 | | 2023-10-02 | director |
| | 2020-11-24 | director |
Jessica Hopfield Latest Holdings Summary
Jessica Hopfield currently owns a total of 5 stocks. Among these stocks, Jessica Hopfield owns 26,917 shares of Insulet Corp (PODD) as of September 11, 2024, with a value of $6 Million and a weighting of 84.39%. Jessica Hopfield owns 61,852 shares of Maravai LifeSciences Holdings Inc (MRVI) as of November 24, 2020, with a value of $485,538 and a weighting of 6.31%. Jessica Hopfield also owns 12,800 shares of Radius Health Inc (RDUS) as of March 5, 2019, with a value of $415,616 and a weighting of 5.4%. The other 2 stocks Editas Medicine Inc (EDIT) , PhenomeX Inc (CELL) have a combined weighting of 3.91% among all his current holdings.
Latest Holdings of Jessica Hopfield
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PODD | Insulet Corp | 2024-09-11 | 26,917 | 241.32 | 6,495,610 |
| MRVI | Maravai LifeSciences Holdings Inc | 2020-11-24 | 61,852 | 7.85 | 485,538 |
| RDUS | Radius Health Inc | 2019-03-05 | 12,800 | 32.47 | 415,616 |
| EDIT | Editas Medicine Inc | 2024-05-13 | 67,700 | 3.12 | 211,224 |
| CELL | PhenomeX Inc | 2022-03-10 | 89,672 | 1.00 | 89,502 |
Holding Weightings of Jessica Hopfield
Jessica Hopfield Form 4 Trading Tracker
According to the SEC Form 4 filings, Jessica Hopfield has made a total of 1 transactions in Insulet Corp (PODD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Insulet Corp is the sale of 7,628 shares on September 11, 2024, which brought Jessica Hopfield around $2 Million.
According to the SEC Form 4 filings, Jessica Hopfield has made a total of 1 transactions in Maravai LifeSciences Holdings Inc (MRVI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Maravai LifeSciences Holdings Inc is the acquisition of 50,000 shares on November 24, 2020, which cost Jessica Hopfield around $1 Million.
According to the SEC Form 4 filings, Jessica Hopfield has made a total of 0 transactions in Radius Health Inc (RDUS) over the past 5 years. The most-recent trade in Radius Health Inc is the acquisition of 12,800 shares on March 5, 2019, which cost Jessica Hopfield around $246,144.
More details on Jessica Hopfield's insider transactions can be found in the Insider Trading History of Jessica Hopfield table.Insider Trading History of Jessica Hopfield
- 1
Jessica Hopfield Trading Performance
GuruFocus tracks the stock performance after each of Jessica Hopfield's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jessica Hopfield is -3.1%. GuruFocus also compares Jessica Hopfield's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jessica Hopfield within 3 months outperforms 3 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jessica Hopfield's insider trading performs compared to the benchmark.
Performance of Jessica Hopfield
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.82 | | | | | |
| Relative Return to S&P 500(%) | 3.26 | | | | | |
Jessica Hopfield Ownership Network
Ownership Network List of Jessica Hopfield
Ownership Network Relation of Jessica Hopfield
Jessica Hopfield Owned Company Details
What does Editas Medicine Inc do?
Who are the key executives at Editas Medicine Inc?
Jessica Hopfield is the director of Editas Medicine Inc. Other key executives at Editas Medicine Inc include SVP & CHIEF MEDICAL OFFICER Baisong Mei , director & CEO Gilmore Neil O'neill , and EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly .
Editas Medicine Inc (EDIT) Insider Trades Summary
Over the past 18 months, Jessica Hopfield made 1 insider transaction in Editas Medicine Inc (EDIT) with a net purchase of 45,000. Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 2,791 shares made by Bruce Eaton , a net sale of 32,292 shares made by Baisong Mei , and a net sale of 98,056 shares made by Gilmore Neil O'neill .
In summary, during the past 3 months, insiders sold 2,073 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 2,073 shares. During the past 18 months, 168,311 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 123,311 shares.
Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Editas Medicine Inc Insider Transactions
Jessica Hopfield Mailing Address
Above is the net worth, insider trading, and ownership report for Jessica Hopfield. You might contact Jessica Hopfield via mailing address: C/o 600 Technology Park Drive, Suite 200, Billerica Ma 01821.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
